aluates Reports

$ 0.0

Automative

Global Ranibizumab Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-3C9418

Global Ranibizumab Market Insights and Forecast to 2028

BUY CHAPTERS

Global Ranibizumab Market Research Report 2025

Code: QYRE-Auto-3C9418

Report

March 2025

Pages:68

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Coherus

Biogen

Ranibizumab Market Size

The global market for Ranibizumab was valued at US$ 2805 million in the year 2024 and is projected to reach a revised size of US$ 1367 million by 2031, growing at a CAGR of -9.9% during the forecast period.

Ranibizumab Market

Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab.

The ranibizumab market is primarily driven by the increasing prevalence of eye diseases such as age-related macular degeneration (AMD), diabetic retinopathy, and macular edema. As the global population ages and diabetes rates rise, the demand for effective treatments like ranibizumab continues to grow. Ranibizumab, an anti-VEGF (vascular endothelial growth factor) therapy, has proven highly effective in reducing vision loss and improving patient outcomes. Additionally, advancements in drug delivery methods, along with expanding healthcare access in emerging markets, are supporting the growth of the ranibizumab market.

One of the key challenges in the ranibizumab market is the high cost of the drug, which can limit patient access, particularly in developing countries or among uninsured populations. While biosimilar versions are being developed, affordability remains a concern. Additionally, there is growing competition from alternative therapies and biosimilars that offer similar efficacy at a lower price. Patient adherence to treatment regimens, which often require frequent intravitreal injections, can also be a challenge, as some patients may find the process uncomfortable or inconvenient.

Global core ranibizumab manufacturers include Roche and Novartis etc. The Top 2 companies hold a share about 98%. North America is the largest market, with a share about 51%, followed by Europe and Asia Pacific with the share about 28% and 20%.

This report aims to provide a comprehensive presentation of the global market for Ranibizumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ranibizumab.

The Ranibizumab market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ranibizumab market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ranibizumab companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Ranibizumab Market Report

Report Metric	Details
Report Name	Ranibizumab Market
Accounted market size in year	US$ 2805 million
Forecasted market size in 2031	US$ 1367 million
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Glass Vial Prefilled Syringe
Segment by Application	Wet AMD Complications of Diabetes RVO Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Coherus, Biogen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ranibizumab company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

What is the Ranibizumab Market size in 2031?

Ans: The Ranibizumab Market size in 2031 will be US$ 1367 million.

What is the market share of major companies in Ranibizumab Market?

Ans: The Top 2 companies hold a share about 98%.

What is the Ranibizumab Market share by region?

Ans: North America is the largest market, with a share about 51%, followed by Europe and Asia Pacific with the share about 28% and 20%.

Who are the main players in the Ranibizumab Market report?

Ans: The main players in the Ranibizumab Market are Roche, Coherus, Biogen

What are the Application segmentation covered in the Ranibizumab Market report?

Ans: The Applications covered in the Ranibizumab Market report are Wet AMD, Complications of Diabetes, RVO, Others

What are the Type segmentation covered in the Ranibizumab Market report?

Ans: The Types covered in the Ranibizumab Market report are Glass Vial, Prefilled Syringe

Recommended Reports

Ophthalmic Drugs

Drug Delivery

Retinal Diseases

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Ranibizumab Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Glass Vial

1.2.3 Prefilled Syringe

1.3 Market by Application

1.3.1 Global Ranibizumab Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Wet AMD

1.3.3 Complications of Diabetes

1.3.4 RVO

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Ranibizumab Market Perspective (2020-2031)

2.2 Global Ranibizumab Growth Trends by Region

2.2.1 Global Ranibizumab Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Ranibizumab Historic Market Size by Region (2020-2025)

2.2.3 Ranibizumab Forecasted Market Size by Region (2026-2031)

2.3 Ranibizumab Market Dynamics

2.3.1 Ranibizumab Industry Trends

2.3.2 Ranibizumab Market Drivers

2.3.3 Ranibizumab Market Challenges

2.3.4 Ranibizumab Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Ranibizumab Players by Revenue

3.1.1 Global Top Ranibizumab Players by Revenue (2020-2025)

3.1.2 Global Ranibizumab Revenue Market Share by Players (2020-2025)

3.2 Global Ranibizumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Ranibizumab Revenue

3.4 Global Ranibizumab Market Concentration Ratio

3.4.1 Global Ranibizumab Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Ranibizumab Revenue in 2024

3.5 Global Key Players of Ranibizumab Head office and Area Served

3.6 Global Key Players of Ranibizumab, Product and Application

3.7 Global Key Players of Ranibizumab, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Ranibizumab Breakdown Data by Type

4.1 Global Ranibizumab Historic Market Size by Type (2020-2025)

4.2 Global Ranibizumab Forecasted Market Size by Type (2026-2031)

5 Ranibizumab Breakdown Data by Application

5.1 Global Ranibizumab Historic Market Size by Application (2020-2025)

5.2 Global Ranibizumab Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Ranibizumab Market Size (2020-2031)

6.2 North America Ranibizumab Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Ranibizumab Market Size by Country (2020-2025)

6.4 North America Ranibizumab Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Ranibizumab Market Size (2020-2031)

7.2 Europe Ranibizumab Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Ranibizumab Market Size by Country (2020-2025)

7.4 Europe Ranibizumab Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Ranibizumab Market Size (2020-2031)

8.2 Asia-Pacific Ranibizumab Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Ranibizumab Market Size by Region (2020-2025)

8.4 Asia-Pacific Ranibizumab Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Ranibizumab Market Size (2020-2031)

9.2 Latin America Ranibizumab Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Ranibizumab Market Size by Country (2020-2025)

9.4 Latin America Ranibizumab Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Ranibizumab Market Size (2020-2031)

10.2 Middle East & Africa Ranibizumab Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Ranibizumab Market Size by Country (2020-2025)

10.4 Middle East & Africa Ranibizumab Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Ranibizumab Introduction

11.1.4 Roche Revenue in Ranibizumab Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Coherus

11.2.1 Coherus Company Details

11.2.2 Coherus Business Overview

11.2.3 Coherus Ranibizumab Introduction

11.2.4 Coherus Revenue in Ranibizumab Business (2020-2025)

11.2.5 Coherus Recent Development

11.3 Biogen

11.3.1 Biogen Company Details

11.3.2 Biogen Business Overview

11.3.3 Biogen Ranibizumab Introduction

11.3.4 Biogen Revenue in Ranibizumab Business (2020-2025)

11.3.5 Biogen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Coherus

Biogen

List of Tables

Table 1. Global Ranibizumab Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Glass Vial

Table 3. Key Players of Prefilled Syringe

Table 4. Global Ranibizumab Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Ranibizumab Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Ranibizumab Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Ranibizumab Market Share by Region (2020-2025)

Table 8. Global Ranibizumab Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Ranibizumab Market Share by Region (2026-2031)

Table 10. Ranibizumab Market Trends

Table 11. Ranibizumab Market Drivers

Table 12. Ranibizumab Market Challenges

Table 13. Ranibizumab Market Restraints

Table 14. Global Ranibizumab Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Ranibizumab Market Share by Players (2020-2025)

Table 16. Global Top Ranibizumab Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ranibizumab as of 2024)

Table 17. Ranking of Global Top Ranibizumab Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Ranibizumab Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Ranibizumab, Headquarters and Area Served

Table 20. Global Key Players of Ranibizumab, Product and Application

Table 21. Global Key Players of Ranibizumab, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Ranibizumab Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Ranibizumab Revenue Market Share by Type (2020-2025)

Table 25. Global Ranibizumab Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Ranibizumab Revenue Market Share by Type (2026-2031)

Table 27. Global Ranibizumab Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Ranibizumab Revenue Market Share by Application (2020-2025)

Table 29. Global Ranibizumab Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Ranibizumab Revenue Market Share by Application (2026-2031)

Table 31. North America Ranibizumab Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Ranibizumab Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Ranibizumab Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Ranibizumab Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Ranibizumab Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Ranibizumab Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Ranibizumab Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Ranibizumab Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Ranibizumab Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Ranibizumab Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Ranibizumab Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Ranibizumab Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Ranibizumab Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Ranibizumab Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Ranibizumab Market Size by Country (2026-2031) & (US$ Million)

Table 46. Roche Company Details

Table 47. Roche Business Overview

Table 48. Roche Ranibizumab Product

Table 49. Roche Revenue in Ranibizumab Business (2020-2025) & (US$ Million)

Table 50. Roche Recent Development

Table 51. Coherus Company Details

Table 52. Coherus Business Overview

Table 53. Coherus Ranibizumab Product

Table 54. Coherus Revenue in Ranibizumab Business (2020-2025) & (US$ Million)

Table 55. Coherus Recent Development

Table 56. Biogen Company Details

Table 57. Biogen Business Overview

Table 58. Biogen Ranibizumab Product

Table 59. Biogen Revenue in Ranibizumab Business (2020-2025) & (US$ Million)

Table 60. Biogen Recent Development

Table 61. Research Programs/Design for This Report

Table 62. Key Data Information from Secondary Sources

Table 63. Key Data Information from Primary Sources

Table 64. Authors List of This Report

List of Figures

Figure 1. Ranibizumab Picture

Figure 2. Global Ranibizumab Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Ranibizumab Market Share by Type: 2024 VS 2031

Figure 4. Glass Vial Features

Figure 5. Prefilled Syringe Features

Figure 6. Global Ranibizumab Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Ranibizumab Market Share by Application: 2024 VS 2031

Figure 8. Wet AMD Case Studies

Figure 9. Complications of Diabetes Case Studies

Figure 10. RVO Case Studies

Figure 11. Others Case Studies

Figure 12. Ranibizumab Report Years Considered

Figure 13. Global Ranibizumab Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Ranibizumab Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Ranibizumab Market Share by Region: 2024 VS 2031

Figure 16. Global Ranibizumab Market Share by Players in 2024

Figure 17. Global Top Ranibizumab Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ranibizumab as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Ranibizumab Revenue in 2024

Figure 19. North America Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Ranibizumab Market Share by Country (2020-2031)

Figure 21. United States Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Ranibizumab Market Share by Country (2020-2031)

Figure 25. Germany Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Ranibizumab Market Share by Region (2020-2031)

Figure 33. China Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Ranibizumab Market Share by Country (2020-2031)

Figure 41. Mexico Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Ranibizumab Market Share by Country (2020-2031)

Figure 45. Turkey Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Roche Revenue Growth Rate in Ranibizumab Business (2020-2025)

Figure 49. Coherus Revenue Growth Rate in Ranibizumab Business (2020-2025)

Figure 50. Biogen Revenue Growth Rate in Ranibizumab Business (2020-2025)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lucentis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lucentis Ranibizumab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ranibizumab Drugs and Biosimilars Market Research Report 2024

Global Bevacizumab Market Insights Forecast to 2030

Global Anti VEGF Drugs for the Treatment of Wet AMD Market Research Report 2024

Bevacizumab Monoclonal Antibody Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ranibizumab Injection Market Research Report 2024

Global Avastin Bevacizumab Biosimilars Market Research Report 2024

Global Broluzumab Biosimilars Market Research Report 2025

Global Monoclonal Antibody Anti VEGF Ophthalmic Drugs Market Research Report 2024

Global Rituximab Biosimilars Market Research Report 2025

Global Monoclonal Antibody VEGF Inhibitors Market Research Report 2024

Global Bevacizumab Generics Market Research Report 2024

Bevacizumab Biosimilar Market

Global Monoclonal antibodies mAbs Biosimilars Market Research Report 2024

Global Berzosertib VE 822 Market Research Report 2024

Global Antibody Drugs Market Insights Forecast to 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions